Latest Articles
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal
Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal
Published: Aug. 7, 2025, 2:48 p.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers
Published: Aug. 6, 2025, 2:27 p.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov
NICE approves first immunotherapy combination for endometrial cancer Wired Gov
Published: Aug. 6, 2025, 1:13 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central
First immunotherapy combination for endometrial cancer approved by NICE Oncology Central
Published: Aug. 6, 2025, 11:18 a.m.
New NHS Drug Option for Advanced Endometrial Cancer - Medscape
New NHS Drug Option for Advanced Endometrial Cancer Medscape
Published: Aug. 6, 2025, 10:54 a.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY
Published: Aug. 6, 2025, 9:30 a.m.
First immunotherapy for advanced endometrial cancer approved in the UK - Open Access Government
First immunotherapy for advanced endometrial cancer approved in the UK Open Access Government
Published: Aug. 6, 2025, 8:50 a.m.
NICE recommends Keytruda for endometrial cancer - The Pharma Letter
NICE recommends Keytruda for endometrial cancer The Pharma Letter
Published: Aug. 6, 2025, 6:49 a.m.
Link copied to clipboard!